You have 9 free searches left this month | for more free features.

FCH-PET/MRI

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

18F-fluorocholine, Positron-Emission Tomography, Hyperparathyroidism, Primary Trial in Toronto ([F-18]-FCH PET/MRI)

Active, not recruiting
  • 18F-fluorocholine
  • +2 more
  • [F-18]-FCH PET/MRI
  • Toronto, Ont, Canada
    UHN
Dec 9, 2022

Prostate Cancer Trial in Australia, Canada, United Kingdom (18F-FCH PET/MRI Scan)

Completed
  • Prostate Cancer
  • 18F-FCH PET/MRI Scan
  • Sydney, New South Wales, Australia
  • +9 more
Apr 4, 2022

An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

Recruiting
  • Prostate Cancer
  • +2 more
  • MRI pelvis or CT imaging
  • +2 more
  • London, Sutton, Surrey, United Kingdom
    Cancer Genetics Unit, Royal Marsden Hospital
Mar 30, 2022

Patients Eligible to a Curative Treatment for Primary HCC Trial in La Tronche, Lyon, Pierre-Bénite (PET/MRI system (SIEMENS AG,

Recruiting
  • Patients Eligible to a Curative Treatment for Primary HCC
  • PET/MRI system (SIEMENS AG, Munich, Germany; distributed in France by SIEMENS S.A.S, Saint-Denis, France)
  • La Tronche, France
  • +3 more
Jan 12, 2021

Brain Metastases Trial in New York (18F-FCH PET Scan)

Completed
  • Brain Metastases
  • 18F-FCH PET Scan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 15, 2022

Myeloma Multiple Trial in Pessac (Positron Emission Tomography using 18F-FCH, Positron Emission Tomography using 18F-FDG)

Recruiting
  • Myeloma Multiple
  • Positron Emission Tomography using 18F-FCH
  • Positron Emission Tomography using 18F-FDG
  • Pessac, France
    Bordeaux University Hospital - Haut-Lévêque
Mar 30, 2022

Multiple Myeloma Trial in Besançon, Dijon (FDG and FCH PET/CT)

Recruiting
  • Multiple Myeloma
  • FDG and FCH PET/CT
  • Besançon, France
  • +2 more
Mar 24, 2022

Contribution of PET/MRI in Locally Advanced Cervical Cancer

Not yet recruiting
  • Cervical Cancer
  • 18-FDG PET-MRI
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Oct 12, 2023

Breast Cancer Female, Lobular Breast Carcinoma, PET/MRI Trial (drug, procedure, genetic)

Not yet recruiting
  • Breast Cancer Female
  • +4 more
  • (no location specified)
Aug 8, 2023

Rectal Cancer Trial (Chemoradiation treatment, 18FDG-PET/MRI scan)

Not yet recruiting
  • Rectal Cancer
  • Chemoradiation treatment
  • 18FDG-PET/MRI scan
  • (no location specified)
Sep 26, 2023

Fluorocholine PET/CT Trial (18F-fluorocholine PET/CT.)

Not yet recruiting
  • Fluorocholine PET/CT
  • 18F-fluorocholine PET/CT.
  • (no location specified)
Oct 24, 2022

Cardiac Sarcoidosis Trial (PET/MRI)

Not yet recruiting
  • Cardiac Sarcoidosis
  • PET/MRI
  • (no location specified)
Jul 26, 2023

Esophageal Cancer Trial in Taoyuan (PET/MRI)

Completed
  • Esophageal Cancer
  • PET/MRI
  • Taoyuan, Taiwan
    Linkou Chang Gung Memorial Hospital
May 9, 2023

Esophagogastric Cancer Trial in Toronto (PET-MRI)

Recruiting
  • Esophagogastric Cancer
  • PET-MRI
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 5, 2023

Hepatocellular Carcinoma Trial in Aarhus (18F-FDGal PET/CT or PET/MRI)

Not yet recruiting
  • Hepatocellular Carcinoma
  • 18F-FDGal PET/CT or PET/MRI
  • Aarhus, Denmark
    Aarhus University Hospital
May 15, 2023

Esophageal Cancer Trial in Taoyuan (PET/MRI)

Completed
  • Esophageal Cancer
  • PET/MRI
  • Taoyuan, Taiwan
    Linkou Chang Gung Memorial Hospital
May 9, 2023

Breast Cancer Trial in Madison (drug, device, other)

Not yet recruiting
  • Breast Cancer
  • Madison, Wisconsin
    UW Carbone Cancer Center
Oct 11, 2023

Response After Neoadjuvant Treatment of Locally Advanced Rectal

Not yet recruiting
  • Rectal Cancer
  • PET-MRI
  • Strasbourg, France
    Institut de cancérologie Strasbourg Europe
Mar 15, 2023

Head Neck Cancer Trial (PET-MRI)

Not yet recruiting
  • Head and Neck Cancer
  • PET-MRI
  • (no location specified)
Sep 4, 2023

Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])

Not yet recruiting
  • Prostate Cancer
  • Piflufolastat F 18 Intravenous Solution [PYLARIFY]
  • (no location specified)
Oct 3, 2023

Hepatocellular Carcinoma Trial (Radiolabelled tracer, 68Gallium-FAPI-46 PET/MRI)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Radiolabelled tracer, 68Gallium-FAPI-46 PET/MRI
  • (no location specified)
Jan 8, 2023

Prostate Cancer Trial (18F-PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Apr 3, 2023

Glioma Trial in Portland (Fludeoxyglucose F-18, Gadoterate Meglumine, Contrast-enhanced Magnetic Resonance Imaging)

Not yet recruiting
  • Glioma
  • Fludeoxyglucose F-18
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 30, 2023

Esophageal Cancer, Esophageal Tumors Trial in Milano (hybrid PET/MRI)

Recruiting
  • Esophageal Cancer
  • Esophageal Neoplasms
  • hybrid PET/MRI
  • Milano, Italy
    Deaprtment of Radiology, IRCCS Ospedale San Raffaele
Jan 24, 2023

Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Chicago (procedure,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Biopsy of Prostate
  • +6 more
  • Chicago, Illinois
    Northwestern University
May 9, 2023